Cangene bioPharma is founded as Chesapeake Biological Laboratories (CBL) in 1980. In December 2009, Chesapeake Biological Laboratories, Inc. is renamed Cangene bioPharma, Inc.It is a contract manufacturer, providing fill/finish services to pharmaceutical and biotechnology companies. The Company aseptically fills liquid and lyophilized products in vials and syringes. It has been inspected and approved by regulatory agencies in the US, EU, and Japan. The specialized development services Cangene bioPharma provides include: development for sterile product formulations, test-method development and validation, process design and manufacturing validations, preparation of clinical trial and toxicology materials, aseptic filling, and accelerated and ongoing stability studies.

Company was acquired by Cangene Corp.